Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling https://www.biorxiv.org/content/10.1101/2023.06.28.546839v1?med=mas
CleverLibre Social is an inclusive social instance for open discussion, learning, and community. All cultures welcome. Hate speech and harassment strictly forbidden.